Photo of Arvin Dar

Arvin Dar, PhD Email Arvin Dar

    • Positions
    • ASSOCIATE PROFESSOR | Oncological Sciences
    • ASSOCIATE PROFESSOR | Pharmacological Sciences
    • Language
    • English

Arvin Dar is Associate Professor, Oncological Sciences and Pharmacological Sciences, and Associate Director of the Mount Sinai Center for Therapeutic Discovery. With a training focus on structural biology and small molecule design and synthesis, Dr. Dar conducts research on developing new therapeutic approaches for disease, particularly small molecule modulators for targeting RAS-driven cancers. His work provides insights into the regulation of oncogenic RAS and offers a foundation for the development of targeted compounds that alter oncogenic signaling complexes. Dr. Dar’s laboratory also investigates target discovery for other disease areas, including hepatocellular carcinoma and rare genetic disorders such as RASopathies and tauopathies. Dr. Dar has received the NIH Director’s New Innovator Award, Damon-Runyon Rachleff Innovation Award, Pew-Stewart Scholarship for Cancer Research, and grant support from the Pershing Square Sohn Cancer Research Alliance, as well as other extramural funding.

Research Topics

Cancer, Drug Design and Discovery, Enzymology, Genetics, Protein Complexes, Structural Biology

Multi-Disciplinary Training Areas

Cancer Biology [CAB], Immunology [IMM], Pharmacology and Therapeutics Discovery [PTD]

Education

BSc, University of Western Ontario

PhD, University of Toronto

Postdoctoral Training, University of California, San Francisco

Language

English